Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AKU Akumin		$0.18	$0.12 ▼ $1.90	$26.32M	-0.72	1.38 million shs	8.54 million shs
AKU Akumin		$0.18	$0.12 ▼ $1.90	$26.32M	-0.72	1.38 million shs	8.54 million shs
RENX Relx	$21.19	$0.00	$20.06 ▼ $23.30	N/A	N/A	100,590 shs	547,934 shs
SQD SQI Diagnostics	C$0.02	C$0.02	C$0.01 ▼ C$0.18	C$6.11M	-0.21	172,133 shs	65,000 shs

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AKU Akumin	0.00%	0.00%	0.00%	0.00%	-52.67%
AKU Akumin	0.00%	0.00%	0.00%	0.00%	-52.67%
RENX Relx	0.00%	0.00%	0.00%	0.00%	0.00%
SQD SQI Diagnostics	0.00%	0.00%	0.00%	0.00%	-70.00%

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AKU Akumin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AKU Akumin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RENX Relx	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SQD SQI Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AKU Akumin	1.50	Reduce	$0.25	∞ Upside
AKU Akumin	1.50	Reduce	$0.25	∞ Upside
RENX Relx	N/A	N/A	N/A	N/A
SQD SQI Diagnostics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AKU Akumin	$749.63M	0.00	N/A	N/A	$1.24 per share	0.00
AKU Akumin	$749.63M	0.00	N/A	N/A	$1.24 per share	0.00
RENX Relx	N/A	N/A	N/A	N/A	N/A	N/A
SQD SQI Diagnostics	C$3.04M	2.01	C$0.00 per share	8.50	C($0.04) per share	-0.38

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AKU Akumin	-$156.76M	-$2.52	N/A	N/A	N/A	-30.56%	-167.86%	-7.81%	N/A
AKU Akumin	-$156.76M	-$2.52	N/A	N/A	N/A	-30.56%	-167.86%	-7.81%	N/A
RENX Relx	N/A	$1.22	17.37	∞	N/A	N/A	N/A	N/A	N/A
SQD SQI Diagnostics	-C$19.14M	-C$0.05	N/A	∞	N/A	N/A	N/A	-74.70%	6/4/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AKU Akumin	N/A	N/A	N/A	N/A	N/A
AKU Akumin	N/A	N/A	N/A	N/A	N/A
RENX Relx	$0.28	1.32%	N/A	22.95%	N/A
SQD SQI Diagnostics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AKU Akumin	17.02	0.99	0.99
AKU Akumin	17.02	0.99	0.99
RENX Relx	N/A	N/A	N/A
SQD SQI Diagnostics	464.33	0.12	0.40

Ownership

Institutional Ownership

Company	Institutional Ownership
AKU Akumin	36.10%
AKU Akumin	36.10%
RENX Relx	1.37%
SQD SQI Diagnostics	25.15%

Insider Ownership

Company	Insider Ownership
AKU Akumin	20.51%
AKU Akumin	20.51%
RENX Relx	N/A
SQD SQI Diagnostics	50.20%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AKU Akumin	3,631	91.17 million	72.47 million	Not Optionable
AKU Akumin	3,631	91.17 million	72.47 million	Not Optionable
RENX Relx	N/A	N/A	N/A	Not Optionable
SQD SQI Diagnostics	147,000	407.17 million	N/A	Not Optionable

RENX, AKU, AKU, and SQD Headlines

Source	Headline
	BVAXF BioVaxys Technology Corp. seekingalpha.com - March 28 at 5:01 PM
	SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing finance.yahoo.com - June 16 at 6:40 PM
	Canadian Investment Regulatory Organization Trading Halt - SQD finance.yahoo.com - June 6 at 10:06 AM
	This SQI Diagnostics Insider Increased Their Holding In The Last Year finance.yahoo.com - May 18 at 1:06 PM
	Closing Bell: Sqi Diagnostics Inc flat on Friday (SQD) theglobeandmail.com - May 17 at 10:10 AM
	Closing Bell: Sqi Diagnostics Inc up on Friday (SQD) theglobeandmail.com - April 29 at 3:21 PM
	Closing Bell: Sqi Diagnostics Inc up on Wednesday (SQD) theglobeandmail.com - April 27 at 12:14 AM
	Closing Bell: Sqi Diagnostics Inc down on Monday (SQD) theglobeandmail.com - April 25 at 2:55 PM
	Closing Bell: Sqi Diagnostics Inc down on Thursday (SQD) theglobeandmail.com - April 21 at 10:35 AM
	Closing Bell: Sqi Diagnostics Inc down on Friday (SQD) theglobeandmail.com - April 15 at 1:43 AM
	Closing Bell: Sqi Diagnostics Inc flat on Wednesday (SQD) theglobeandmail.com - April 12 at 11:06 PM
	Closing Bell: Sqi Diagnostics Inc flat on Tuesday (SQD) theglobeandmail.com - April 11 at 9:11 PM
	SQI DIAGNOSTICS ANNOUNCES ISSUANCE OF PREVIOUSLY ANNOUNCED BONUS WARRANTS finance.yahoo.com - March 20 at 7:09 PM
	SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND DEFERRAL OF CERTAIN INTEREST PAYMENTS ca.finance.yahoo.com - February 6 at 8:47 AM
	The Independent Director of SQI Diagnostics Inc. (CVE:SQD), Gerald Connor, Just Bought 5.8% More Shares finance.yahoo.com - December 9 at 7:16 AM
	SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND ANNOUNCES DEFERRAL OF CERTAIN INTEREST PAYMENTS finance.yahoo.com - October 19 at 5:59 PM
	SQI Diagnostics: Top 10 Undervalued Medical Diagnostics & Research Industry Sector Stocks on TSX Venture Exchange (SQD) theglobeandmail.com - September 19 at 12:56 AM
	SQI Diagnostics reports Q3 results seekingalpha.com - August 30 at 11:19 PM
	New York State Approves SQI Diagnostics' EXACT COVID-19 Antibody Assay finance.yahoo.com - March 3 at 4:45 PM
	SQI DIAGNOSTICS PROVIDES UPDATE ON PREVIOUSLY ANNOUNCED ASSET PURCHASE TRANSACTION WITH PRECISION BIOMONITORING newswire.ca - February 10 at 6:47 AM
	SQI DIAGNOSTICS PROVIDES UPDATE ON PREVIOUSLY ANNOUNCED ASSET PURCHASE TRANSACTION WITH PBI DIAGNOSTICS finance.yahoo.com - February 9 at 8:46 PM
	Stocks in play: SQI Diagnostics Inc ca.finance.yahoo.com - January 31 at 4:56 PM
	Wilmot Matthews Is The Non-Independent Director of SQI Diagnostics Inc. (CVE:SQD) And They Just Picked Up 8.1% More Shares yahoo.com - November 6 at 10:05 AM
	SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options wfmz.com - September 13 at 6:16 PM

Company Descriptions

Akumin

NASDAQ:AKU

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

Akumin

NASDAQ:AKU

Relx

NYSE:RENX

RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry specific content with technology and analytics to evaluate and predict risk, as well as enhance operational efficiency. The Legal segment offers legal, regulatory, and business information and analytics. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier NV and changed its name to RELX NV in June 2015. RELX NV was incorporated in 1880 and is headquartered in Amsterdam, the Netherlands.

SQI Diagnostics

CVE:SQD

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Price Performance

MarketRank™

Analyst Ratings

Current Analyst Ratings

Sales & Book Value

Profitability & Earnings

Dividends

Debt

Ownership

Institutional Ownership

Insider Ownership

Miscellaneous

RENX, AKU, AKU, and SQD Headlines

Company Descriptions

Akumin

Akumin

Relx

SQI Diagnostics

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info